| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/28/2013 | US20130052740 Copper, starch and iodide moisture indicator |
| 02/28/2013 | US20130052672 Kit for measuring the thrombin generation in a sample of a sample of a patient's blood or plasma |
| 02/28/2013 | US20130052670 Method for detection of amyloid beta oligomers in a fluid sample and uses thereof |
| 02/28/2013 | US20130052669 Compositions and methods for reliably detecting and/or measuring the amount of a modified target protein in a sample |
| 02/28/2013 | US20130052668 Identification and use of biomarkers for detection and quantification of the level of radiation exposure in a biological sample |
| 02/28/2013 | US20130052667 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 02/28/2013 | US20130052666 Antibody against human tsh and canine tsh |
| 02/28/2013 | US20130052665 Methods for diagnosis of systemic juvenile idiopathic arthritis |
| 02/28/2013 | US20130052664 Method and kit for isolating target cell |
| 02/28/2013 | US20130052663 Chimeric Receptors and Methods for Identifying Agents Exhibiting an Activity on Type 1 Single Pass Transmembrane Receptors |
| 02/28/2013 | US20130052661 Methods for Biomolecule and Biomolecule Complex (BMC) Detection and Analysis and the Use of Such for Research and Medical Diagnosis |
| 02/28/2013 | US20130052659 METHOD FOR MEASURING IgG-MEDIATED COMPLEMENT ACTIVATION |
| 02/28/2013 | US20130052658 Method of reducing interference from component outside of measurement system |
| 02/28/2013 | US20130052657 Measurement method for physiologically active substance of biological origin, and reagent kit for measurement |
| 02/28/2013 | US20130052654 Amyloid Precursor Protein E2 Domain and Uses Thereof |
| 02/28/2013 | US20130052653 Devices for detection of analytes |
| 02/28/2013 | US20130052644 Predictive Markers Useful in the Treatment of Fragile X Syndrome (FXS) |
| 02/28/2013 | US20130052643 Method for generating nuclear reprogrammed cell, and use thereof |
| 02/28/2013 | US20130052642 Method for the identification and purification of human naturally occurring regulatory t cells (ntregs) |
| 02/28/2013 | US20130052640 Clostridium difficile dehydrogenase and toxin as a biomarker for monitoring infection in patients with clostridium difficile disease and differentiating carrier state from active disease |
| 02/28/2013 | US20130052310 Cooking Appliance and Automatic Shut-Off Method for Same |
| 02/28/2013 | US20130052211 Vaccines with oncofetal antigen/ilrp-loaded autologous dendritic cells and uses thereof |
| 02/28/2013 | US20130052207 Prognostic Method for Pulmonary Adenocarcinoma, Pulmonary Adenocarcinoma Detection Kit, and Pharmaceutical Composition for Treating Pulmonary Adenocarcinoma |
| 02/28/2013 | US20130052205 Flt3 receptor antagonists for the treatment or the prevention of pain disorders |
| 02/28/2013 | US20130052202 HIGH AFFINITY, ANTI-HUMAN IgE ANTIBODIES |
| 02/28/2013 | US20130052198 Anti-inflammatory factors |
| 02/28/2013 | US20130052194 Anti-prostate cancer antibodies and methods of detection and treatment of prostate cancer using the same |
| 02/28/2013 | US20130052186 Plasma Carboxypeptidase B as a Predictor for Disease Severity and Response |
| 02/28/2013 | US20130052160 Compounds and uses thereof to induce an immunogenic cancer cell death in a subject |
| 02/28/2013 | US20130052136 Methods and apparatuses for predicting the effects of erythropoiesis stimulating agents, and for determining a dose to be administered |
| 02/28/2013 | US20130052135 Molecules With Extended Half-Lives, Compositions And Uses Thereof |
| 02/28/2013 | US20130052128 Upar Binding Agents and Methods of Use Thereof |
| 02/28/2013 | US20130052081 Detection system for high sensitivity fluorescent assays |
| 02/28/2013 | US20130050459 Biosensor with a visually identifiable character pattern, and biosensor measuring system incorporating the same |
| 02/28/2013 | US20130048495 Analyte sensors and systems including retention tab and methods of manufacturing same |
| 02/28/2013 | US20130048487 Systems and methods for enrichment and detection of particles |
| 02/28/2013 | US20130047963 Warranty violation detection system for disallowed fuels |
| 02/28/2013 | US20130047708 Method and system for measuring engine oil deterioration |
| 02/28/2013 | DE102011120268B3 Quantitatively determining concentration of biomass formed by culturing in closed bioreactor, comprises e.g. determining constant factor, calculating electrical conductivities or glucose concentrations, and determining biomass concentration |
| 02/28/2013 | DE102011081703A1 Method for operating household appliance with flow-type heater, involves determining harness value of water upstream flow-type heater and determining hardness value of water downstream flow-type heater |
| 02/28/2013 | DE102011081472A1 Medical sensor system useful in medical implant for detecting at least one feature of animal and/or human body, comprises at least one sensor, first feature carrier, second feature carrier and feature carrier receptor |
| 02/28/2013 | DE102011081328A1 Flüssiges Gemisch zum Testen und Validieren von Prüfgeräten zur Überprüfung von Gegenständen oder Personen Liquid mixture for testing and validation of test equipment for testing of objects or people |
| 02/28/2013 | DE102011057188A1 Verfahren und System zum Messen einer Motorölverschlechterung Method and system for measuring an engine oil deterioration |
| 02/28/2013 | DE102007034749B4 Peptidderivatisierungsverfahren zum Erhöhen von Fragmentierungsinformationen aus MS/MS-Spektren Peptidderivatisierungsverfahren for increasing fragmentation information from MS / MS spectra |
| 02/28/2013 | CA2846494A1 Compounds for use in boosting coagulation |
| 02/28/2013 | CA2846385A1 Improved vaccine diagnostics |
| 02/28/2013 | CA2845756A1 Method of drug repositioning |
| 02/28/2013 | CA2844920A1 Ir spectrometry cell with temperature control means |
| 02/28/2013 | CA2843756A1 Renal cell carcinoma biomarkers and uses thereof |
| 02/28/2013 | CA2843752A1 Rapid detection of metabolic activity |
| 02/28/2013 | CA2788785A1 Apparatus, system, and method for implementing and monitoring breath alcohol testing programs, usually from a fixed point location, such as a home |
| 02/27/2013 | EP2562546A2 Detection of endometrial secretion markers for assesment of endometriosis& xA; |
| 02/27/2013 | EP2562545A1 Methods and compositions relating to Alzheimer's disease |
| 02/27/2013 | EP2562544A1 kits for use in the differentiation of IBD and IBS and further distinction between disease types of IBD |
| 02/27/2013 | EP2562543A1 Composition and method for measuring thallium influx and efflux |
| 02/27/2013 | EP2562542A1 Dynamically determining the thrombocyte function |
| 02/27/2013 | EP2562541A1 High precision detection of the volume proportion of a component in a multicomponent fluid |
| 02/27/2013 | EP2562536A1 Analyte detection method and analyte detection integrated circuit |
| 02/27/2013 | EP2562533A1 Membrane potential change detection device and membrane potential change detection method |
| 02/27/2013 | EP2562255A1 Nucleic acid base analog with quenching characteristics and fluorescence and application thereof |
| 02/27/2013 | EP2562185A1 Antibody against human TSH and canine TSH |
| 02/27/2013 | EP2561887A2 Cancer therapy sensitizer |
| 02/27/2013 | EP2561368A2 Compositions and methods for prediction of drug sensitivity, resistance, and disease progression |
| 02/27/2013 | EP2561367A1 Means and methods for identifying an increased risk of systemic lupus erythematosus (sle) patients for developing renal manifestations |
| 02/27/2013 | EP2561366A1 Cxcl5 as a marker of hormone escape in prostate cancer |
| 02/27/2013 | EP2561365A2 Methods of identifying & using anti-viral compounds |
| 02/27/2013 | EP2561364A2 Method and apparatus for forming of an automated sampling device for the detection of salmonella enterica utilizing an electrochemical aptamer biosensor |
| 02/27/2013 | EP2561363A2 Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof |
| 02/27/2013 | EP2561362A2 Method for detecting a salmonella infection |
| 02/27/2013 | EP2561361A1 Compositions and methods for isolating mid-log phase bacteria |
| 02/27/2013 | EP2561360A1 Isolating a target analyte from a body fluid |
| 02/27/2013 | EP2561359A1 Chimeric polypeptides useful in proximal and dynamic high-throughput screening methods |
| 02/27/2013 | EP2561358A2 Diagnostic assay |
| 02/27/2013 | EP2561357A1 Dna intercalator detection |
| 02/27/2013 | EP2561356A1 MOLECULES AND METHODS OF USING SAME FOR TREATING ErbB/ErbB LIGANDS ASSOCIATED DISEASES |
| 02/27/2013 | EP2561355A1 Method for diagnosing melanocytic proliferations |
| 02/27/2013 | EP2561354A1 Extractin low concentrations of bacteria from a sample |
| 02/27/2013 | EP2561353A1 Predictors of pharmacokinetic and pharmacodynamic disposition of carrier-mediated agents |
| 02/27/2013 | EP2561352A1 Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof |
| 02/27/2013 | EP2561351A2 Novel biomarkers and targets for ovarian carcinoma |
| 02/27/2013 | EP2561350A1 Method and system for analyzing a blood sample |
| 02/27/2013 | EP2561349A1 Biofuel degradation sensor based on fluorescence measurements |
| 02/27/2013 | EP2561348A2 Methods and apparatus for determination of halohydrocarbons |
| 02/27/2013 | EP2561347A2 Epicutaneous patch test chamber |
| 02/27/2013 | EP2561346A1 Radioactive/nuclear threat monitoring using long detectors |
| 02/27/2013 | EP2561344A2 Gas analyte spectrum sharpening and separation with multi-dimensional micro-gc for gas chromatography analysis |
| 02/27/2013 | EP2561341A1 Functionalizing biosensors using a multiplexed dip pen array |
| 02/27/2013 | EP2561337A1 Multi-pillar structure for molecular analysis |
| 02/27/2013 | EP2561334A1 Products and methods for tissue preservation |
| 02/27/2013 | EP2561099A1 Separating target analytes using alternating magnetic fields |
| 02/27/2013 | EP2561098A1 Tethered enzyme mediated nucleic acid detection |
| 02/27/2013 | EP2561082A1 Fumarylacetoacetate hydrolase (fah)-deficient pigs and uses thereof |
| 02/27/2013 | EP2560995A1 Assay for identification of lrrk2 inhibitors |
| 02/27/2013 | EP2560990A1 Novel allergen |
| 02/27/2013 | EP2560989A1 Cancer-related glycopeptide epitopes, antibodies and methods of use |
| 02/27/2013 | EP2560757A1 Device for preparing and/or treating a biological sample |
| 02/27/2013 | EP2560756A1 Device for plasma separation by means of a central channel structure |
| 02/27/2013 | EP2560667A1 Method to detect endothelial cell massive calcium accumulation death |
| 02/27/2013 | CN202757943U Helicobacter (HP) current infection current infection marker (CIM) rapid detecting reagent kit |
| 02/27/2013 | CN202757942U Ferritin radioactive labeling assay kit |